Stille

Stille Capital Intensity

The Capital Intensity Ratio of Stille (STIL.ST) as of Oct 24, 2026 is 185.73 %. In the previous year, Capital Intensity Ratio was 175.65 % — a change of 5.74% (higher).

Capital Intensity

185.73 %

YoY

5.74%

Last updated:

Capital Intensity Ratio of Stille is 2025 185.73 % . Capital Intensity Ratio of Stille was 2024 175.65 % . It decreases by 5.74% higher compared to the previous year.

The Stille Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2018
84.91 SEK
Jan 1, 2019
103.69 SEK
Jan 1, 2020
115.62 SEK
Jan 1, 2021
165.09 SEK
Jan 1, 2022
139.05 SEK
Jan 1, 2023
272.94 SEK
Jan 1, 2024
175.65 SEK
Jan 1, 2025
185.73 SEK
The Stille Capital Intensity history
YEARCapital IntensityYoY
185.73 %+5.74%
175.65 %-35.65%
272.94 %+96.29%
139.05 %-15.77%
165.09 %+42.79%
115.62 %+11.50%
103.69 %+22.12%
84.91 %+12.01%
75.80 %-9.20%
83.48 %+0.26%
83.26 %+21.80%
68.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

Capital Intensity Ratio of Stille is 185.73 % in 2025.

Capital Intensity Ratio of Stille changed from 175.65 % to 185.73 %, representing a 5.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Stille since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Stille with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Stille

All Key Metrics — Stille